LMR Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

LMR Partners’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-45,281	Closed	-$14.7M	–	1378
2024 Q1	$14.7M	Buy	+45,281	New	+$11.1M	0.15%	141
2023 Q4	–	Sell	-5,800	Closed	-$1.15M	–	1173
2023 Q3	$1.15M	Buy	5,800 +1,705	+42%	+$403K	0.01%	459
2023 Q2	$1.17M	Buy	+4,095	New	+$1.14M	0.01%	403

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

LMR Partners's SWAV Position: Q2 2024 in Review

LMR Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 45,281 shares — an estimated $14.7M sold.

LMR Partners first reported a position in SWAV in Q2 2023 and held it in 3 quarters. The position peaked at $14.7M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

LMR Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
LMR Partners sold 45,281 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $14.7M.
LMR Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
LMR Partners's Shockwave Medical, Inc. Common Stock position peaked at $14.7M in Q1 2024.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.